Literature DB >> 19058963

Microwave-assisted one step synthesis of 8-arylmethyl-9H-purin-6-amines.

Hui Tao1, Yanlong Kang, Tony Taldone, Gabriela Chiosis.   

Abstract

Molecular chaperone heat shock protein 90 (Hsp90) is an important target in cancer and neurodegenerative diseases, and has rapidly become the focus of several drug discovery efforts. Among small molecule Hsp90 inhibitors with clinical applicability are derivatives of 8-arylmethyl-9H-purin-6-amine class. Here we report the use of microwave-assisted chemistry for the successful one-pot delivery of 8-arylmethyl-9H-purin-6-amines. We discuss the applicability as well as the limitations of this method towards the creation of a large chemical diversity in the 8-arylmethyl-9H-purin-6-amine series.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058963      PMCID: PMC2732337          DOI: 10.1016/j.bmcl.2008.11.057

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.

Authors:  Huazhong He; Danuta Zatorska; Joungnam Kim; Julia Aguirre; Laura Llauger; Yuhong She; Nian Wu; Robert M Immormino; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

Review 2.  Controlled microwave heating in modern organic synthesis.

Authors:  C Oliver Kappe
Journal:  Angew Chem Int Ed Engl       Date:  2004-11-26       Impact factor: 15.336

3.  A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells.

Authors:  G Chiosis; M N Timaul; B Lucas; P N Munster; F F Zheng; L Sepp-Lorenzino; N Rosen
Journal:  Chem Biol       Date:  2001-03

Review 4.  Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.

Authors:  Gabriela Chiosis; Eloisi Caldas Lopes; David Solit
Journal:  Curr Opin Investig Drugs       Date:  2006-06

Review 5.  Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.

Authors:  Gabriela Chiosis
Journal:  Expert Opin Ther Targets       Date:  2006-02       Impact factor: 6.902

6.  Discovery and development of purine-scaffold Hsp90 inhibitors.

Authors:  Gabriela Chiosis; Yanlong Kang; Weilin Sun
Journal:  Expert Opin Drug Discov       Date:  2008-01       Impact factor: 6.098

7.  Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.

Authors:  Wenjie Luo; Fei Dou; Anna Rodina; Sophorn Chip; Joungnam Kim; Qi Zhao; Kamalika Moulick; Julia Aguirre; Nian Wu; Paul Greengard; Gabriela Chiosis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

8.  Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.

Authors:  Maria Vilenchik; David Solit; Andrea Basso; Henri Huezo; Brian Lucas; Huazhong He; Neal Rosen; Claudia Spampinato; Paul Modrich; Gabriela Chiosis
Journal:  Chem Biol       Date:  2004-06

9.  Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures.

Authors:  Brian Dymock; Xavier Barril; Mandy Beswick; Adam Collier; Nicholas Davies; Martin Drysdale; Alexandra Fink; Christophe Fromont; Roderick E Hubbard; Andrew Massey; Allan Surgenor; Lisa Wright
Journal:  Bioorg Med Chem Lett       Date:  2004-01-19       Impact factor: 2.823

Review 10.  Therapeutic and diagnostic implications of Hsp90 activation.

Authors:  Adeela Kamal; Marcus F Boehm; Francis J Burrows
Journal:  Trends Mol Med       Date:  2004-06       Impact factor: 11.951

View more
  1 in total

1.  Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Authors:  Hardik J Patel; Pallav D Patel; Stefan O Ochiana; Pengrong Yan; Weilin Sun; Maulik R Patel; Smit K Shah; Elisa Tramentozzi; James Brooks; Alexander Bolaender; Liza Shrestha; Ralph Stephani; Paola Finotti; Cynthia Leifer; Zihai Li; Daniel T Gewirth; Tony Taldone; Gabriela Chiosis
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.